Consulting and Custom Research
Led by Dr. Kenneth Brouwer, Chief Scientific Officer, our senior scientists provide consulting support on in vitro hepatic models and research. We help our clients outline their strategy for regulatory submissions, including, predicting the potential impact of the liver on their compounds, and the effects of their compounds on the liver, analyze data from studies, and author reports suitable for integration into regulatory submissions.
In addition to standard studies typically implemented in R&D programs and for regulatory approval, we design and implement novel experiments to address our clients’ research questions. Our platform technologies can be used to study a broad array of liver-related research questions.